Month: September 2022
-
Start-Up Developing Efficient RNA Process, Raises $12M
A company formed earlier this year is commercializing a more efficient process for making synthetic RNA molecules and raising $12 million in seed funds.
-
Stem Cell Lab Planned for Commercial Space Station
A collaboration between university researchers and a space science company is designing a stem cell research lab on a proposed commercial space station.
-
Company Formed to Boost Clinical Trial Success Odds
A pharma/tech industry group is starting a new company to use algorithms for finding gaps in preclinical data that can impair clinical trial progress.
-
Start-Up Licenses Gene-Edited Drug Discovery Tech.
A new company is acquiring a technology using genome-edited tadpoles that finds current drugs addressing precise genetic conditions underlying rare diseases.
-
Rosh Hashanah 5783
Science and Enterprise is taking off today to observe Rosh Hashanah, the Jewish new year.
-
Infographic – Earth Orbits Getting More Crowded
The rate of new earth-orbit launches is accelerating, with OECD expecting tens of thousands of new satellites launched in the next five years.
-
NIH Funds Decentralized Rare Disease Data Network
A start-up company is building a secure decentralized network of genomic and other medical data on rare diseases, funded by a fast-track award from an NIH agency.
-
FDA Clearance Requested for Behavioral Diabetes Therapy
A digital health company is asking for FDA authorization to market a mobile app that helps treat type 2 diabetes with cognitive behavioral therapy.
-
Trial Underway Assessing Gut Microbiome-Cancer Links
A clinical trial began collecting stool and blood samples to find connections between microbial communities in the gut and four types of solid-tumor cancer.
-
Challenge Seeks Animal-Free Testing for Precision Meds.
A charitable foundation promoting research on human longevity unveiled a challenge competition to develop animal-free testing for personalized medicine.